These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33279767)

  • 1. A comprehensive analytical process, from NPS threat identification to systematic screening: Method validation and one-year prevalence study.
    Garneau B; Desharnais B; Laquerre J; Côté C; Taillon MP; Martin PY; Daigneault G; Mireault P; Lajeunesse A
    Forensic Sci Int; 2021 Jan; 318():110595. PubMed ID: 33279767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a rapid LC-MS/MS method for the detection of 182 novel psychoactive substances in whole blood.
    Giorgetti A; Barone R; Pelletti G; Garagnani M; Pascali J; Haschimi B; Auwärter V
    Drug Test Anal; 2022 Feb; 14(2):202-223. PubMed ID: 34599648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases.
    Vaiano F; Busardò FP; Palumbo D; Kyriakou C; Fioravanti A; Catalani V; Mari F; Bertol E
    J Pharm Biomed Anal; 2016 Sep; 129():441-449. PubMed ID: 27490334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography-Tandem Quadrupole Mass Spectrometry (LC-QQQ-MS).
    Walton SE; Krotulski AJ; Logan BK
    J Anal Toxicol; 2022 Mar; 46(3):221-231. PubMed ID: 34792157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
    Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
    Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and concentrations of new designer stimulants, synthetic opioids, benzodiazepines, and hallucinogens in postmortem hair samples: A 13-year retrospective study.
    Niebel A; Westendorf L; Krumbiegel F; Hartwig S; Parr MK; Tsokos M
    Drug Test Anal; 2022 Jan; 14(1):110-121. PubMed ID: 34435749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS).
    Fagiola M; Hahn T; Avella J
    J Anal Toxicol; 2018 Oct; 42(8):562-569. PubMed ID: 30371846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a simultaneous screening method for the detection of new psychoactive substances in various matrix samples using liquid chromatography/electrospray ionization tandem mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Kim NS; Lim NY; Choi HS; Lee JH; Kim H; Baek SY
    Rapid Commun Mass Spectrom; 2021 May; 35(10):e9067. PubMed ID: 33656207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a fast UPLC-MS/MS screening method for the detection of 68 psychoactive drugs and metabolites in whole blood and application to post-mortem cases.
    Barone R; Giorgetti A; Cardella R; Rossi F; Garagnani M; Pascali JP; Mohamed S; Fais P; Pelletti G
    J Pharm Biomed Anal; 2023 May; 228():115315. PubMed ID: 36889130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry.
    Adamowicz P; Tokarczyk B
    Drug Test Anal; 2016 Jul; 8(7):652-67. PubMed ID: 25976069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of Traditional and Designer Benzodiazepines in Urine through LC-MS/MS.
    Rossi B; Freni F; Carelli C; Moretti M; Galatone D; Vignali C; Morini L
    Curr Pharm Des; 2022; 28(32):2622-2638. PubMed ID: 36045516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples.
    Kinyua J; Negreira N; Ibáñez M; Bijlsma L; Hernández F; Covaci A; van Nuijs AL
    Anal Bioanal Chem; 2015 Nov; 407(29):8773-85. PubMed ID: 26396082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective screening of new psychoactive substances (NPS) in post mortem samples from 2014 to 2021.
    Gundersen POM; Pasin D; Slørdal L; Spigset O; Josefsson M
    Forensic Sci Int; 2024 Aug; 361():112131. PubMed ID: 38981414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700.
    Richeval C; Gaulier JM; Romeuf L; Allorge D; Gaillard Y
    Int J Legal Med; 2019 Jan; 133(1):133-142. PubMed ID: 30443678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical Strategies to Disclose Repeated Consumption of New Psychoactive Substances by Hair Analysis.
    Rotolo MC; Klein J; Pacifici R; Busardo FP; Pichini S; Marchei E
    Curr Pharm Biotechnol; 2017; 18(10):834-839. PubMed ID: 29173161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a sensitive untargeted liquid chromatography-high resolution mass spectrometry screening devoted to hair analysis through a shared MS2 spectra database: A step toward early detection of new psychoactive substances.
    Fabresse N; Larabi IA; Stratton T; Mistrik R; Pfau G; Lorin de la Grandmaison G; Etting I; Grassin Delyle S; Alvarez JC
    Drug Test Anal; 2019 May; 11(5):697-708. PubMed ID: 30394697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology - An update.
    Remane D; Wissenbach DK; Peters FT
    Clin Biochem; 2016 Sep; 49(13-14):1051-71. PubMed ID: 27452180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and quantification of synthetic cathinones and selected piperazines in hair by LC-MS/MS.
    Niebel A; Krumbiegel F; Hartwig S; Parr MK; Tsokos M
    Forensic Sci Med Pathol; 2020 Mar; 16(1):32-42. PubMed ID: 31853826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput screening for new psychoactive substances (NPS) in whole blood by DLLME extraction and UHPLC-MS/MS analysis.
    Odoardi S; Fisichella M; Romolo FS; Strano-Rossi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():57-68. PubMed ID: 26209771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of U-47700 and its metabolites in plasma by LC-MS/MS.
    Smith CR; Truver MT; Swortwood MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():41-47. PubMed ID: 30849683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.